For years, Yale researchers David Breslow and Mustafa Khokha have worked together with a similar challenge in their ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...
In this interview conducted at SLAS EU 2023 in Brussels, Belgium, we spoke to Ulrike Künzel, Associate Director in the Functional Genomics department at AstraZeneca, about the application of arrayed ...
Researchers used CRISPR to change the number of chromosomes in Arabidopsis by fusing chromosome arms, reducing the genome ...
The University of California Berkeley and UC San Francisco announced this week the launch of the Laboratory for Genomics Research, in which scientists from both institutions will use CRISPR gene ...
Third Rock Ventures has launched a new cancer drug discovery and development company, Tango Therapeutics, with a $55 million Series A investment. The new firm, based in Cambridge, MA, is exploiting a ...
CRISPR gene editing has revolutionized the field of molecular biology, offering precise, efficient, and versatile tools for genome modification. The technology has rapidly evolved beyond the original ...
Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), a global leader in gene editing and gene modulation technologies, today announced the extension of its CRISPR Screening Service to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results